Rigel Pharmaceuticals Inc (RIGL) 뉴스

Form 8-K - Current report

Rigel Provides Business Update and 2025 Outlook

Rigel Provides Business Update and 2025 Outlook PR Newswire SOUTH SAN FRANCISCO, Calif., Jan. 13, 2025...

Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS

Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS PR Newswire SOUTH SAN FRANCISCO...

Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif...

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire SOUTH...

Form 8-K - Current report

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition

Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual...

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS

Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS PR Newswire SOUTH SAN...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Rigel to Present at the Jefferies London Healthcare Conference

Rigel to Present at the Jefferies London Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif., Nov...

Form 8-K - Current report